US Stock MarketDetailed Quotes

Arcturus Therapeutics (ARCT)

Watchlist
  • 8.360
  • +0.140+1.70%
Close Apr 10 16:00 ET
  • 8.230
  • -0.130-1.56%
Post 20:01 ET
237.62MMarket Cap-3.48P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arcturus Therapeutics (ARCT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-51.43%67.22M
-85.33%3.08M
-63.54%14.15M
-46.69%24.51M
-21.84%25.48M
-12.27%138.39M
-16.26%21M
-10.52%38.82M
380.67%45.98M
-59.11%32.6M
Operating revenue
-51.43%67.22M
-85.33%3.08M
-63.54%14.15M
-46.69%24.51M
-21.84%25.48M
-12.27%138.39M
-16.26%21M
-10.52%38.82M
380.67%45.98M
-59.11%32.6M
Cost of revenue
Gross profit
Operating expense
-38.70%143.48M
-36.78%34.39M
-38.12%30.67M
-46.16%36.13M
-32.86%42.3M
-0.80%234.06M
25.48%54.39M
-20.96%49.55M
3.33%67.1M
-3.02%63.01M
Selling and administrative expenses
-12.77%46.08M
13.30%14.03M
-21.68%10.4M
-16.06%10.34M
-23.81%11.32M
-0.09%52.82M
-1.02%12.38M
-0.76%13.28M
-6.87%12.32M
7.91%14.85M
-General and administrative expense
-12.77%46.08M
13.30%14.03M
-21.68%10.4M
-16.06%10.34M
-23.81%11.32M
-0.09%52.82M
-1.02%12.38M
-0.76%13.28M
-6.87%12.32M
7.91%14.85M
Research and development costs
-42.50%112.21M
-44.09%24.48M
-40.55%23.27M
-49.58%29.58M
-34.87%34.89M
1.57%195.16M
19.55%43.78M
-23.38%39.13M
11.39%58.67M
3.49%53.57M
Other operating expenses
-6.39%-14.81M
-133.01%-4.12M
-4.90%-3M
2.37%-3.79M
27.87%-3.91M
-53.81%-13.92M
69.43%-1.77M
-62.02%-2.86M
-307.02%-3.88M
-873.74%-5.41M
Operating profit
20.29%-76.26M
6.25%-31.31M
-53.79%-16.51M
45.02%-11.62M
44.67%-16.83M
-22.33%-95.67M
-82.76%-33.39M
44.41%-10.74M
61.85%-21.13M
-306.11%-30.41M
Net non-operating interest income expense
-33.56%10.1M
-52.61%1.52M
-15.30%3.23M
-38.11%2.57M
-31.00%2.77M
-8.41%15.2M
-53.29%3.21M
-4.09%3.82M
27.55%4.15M
62.13%4.02M
Non-operating interest income
-33.50%10.1M
-52.33%1.53M
-15.30%3.23M
-38.11%2.57M
-31.00%2.77M
-12.47%15.2M
-53.33%3.21M
-4.57%3.82M
27.55%4.15M
24.72%4.02M
Non-operating interest expense
--9K
----
----
----
----
--0
--0
--0
--0
--0
Other net income (expense)
181.10%382K
309.94%701K
15.42%-170K
67.27%-127K
60.38%-21K
-101.40%-471K
416.67%171K
-5,125.00%-201K
-360.40%-388K
-100.16%-53K
Gain on sale of security
181.10%382K
309.94%701K
15.42%-170K
67.27%-127K
60.38%-21K
-105.68%-471K
416.67%171K
-5,125.00%-201K
-360.40%-388K
83.84%-53K
Earnings from equity interest
----
----
----
----
----
--0
----
----
----
----
Special income (charges)
--0
----
----
----
----
--0
--0
--0
--0
--0
Income before tax
18.73%-65.78M
3.09%-29.08M
-88.88%-13.45M
47.16%-9.18M
46.78%-14.08M
-190.23%-80.95M
-162.20%-30.01M
53.55%-7.12M
66.59%-17.37M
-152.01%-26.45M
Income tax
0
0.00%-4K
0
102.67%4K
0
-100.22%-4K
-101.53%-4K
-124.30%-217K
-126.00%-150K
257.28%368K
Net income
18.73%-65.78M
3.09%-29.08M
-94.81%-13.45M
46.68%-9.18M
47.51%-14.08M
-172.30%-80.94M
-156.30%-30.01M
57.45%-6.9M
67.24%-17.22M
-152.84%-26.82M
Net income continuous Operations
18.73%-65.78M
3.09%-29.08M
-94.81%-13.45M
46.68%-9.18M
47.51%-14.08M
-172.30%-80.94M
-156.30%-30.01M
57.45%-6.9M
67.24%-17.22M
-152.84%-26.82M
Minority interest income
Net income attributable to the parent company
18.73%-65.78M
3.09%-29.08M
-94.81%-13.45M
46.68%-9.18M
47.51%-14.08M
-172.30%-80.94M
-156.30%-30.01M
57.45%-6.9M
67.24%-17.22M
-152.84%-26.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
18.73%-65.78M
3.09%-29.08M
-94.81%-13.45M
46.68%-9.18M
47.51%-14.08M
-172.30%-80.94M
-156.30%-30.01M
57.45%-6.9M
67.24%-17.22M
-152.84%-26.82M
Basic earnings per share
20.00%-2.4
7.21%-1.03
-88.46%-0.49
46.88%-0.34
48.00%-0.52
-167.86%-3
-246.88%-1.11
57.38%-0.26
67.68%-0.64
-152.36%-1
Diluted earnings per share
20.00%-2.4
7.21%-1.03
-88.46%-0.49
46.88%-0.34
48.00%-0.52
-167.86%-3
-246.88%-1.11
57.38%-0.26
67.68%-0.64
-153.48%-1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -51.43%67.22M-85.33%3.08M-63.54%14.15M-46.69%24.51M-21.84%25.48M-12.27%138.39M-16.26%21M-10.52%38.82M380.67%45.98M-59.11%32.6M
Operating revenue -51.43%67.22M-85.33%3.08M-63.54%14.15M-46.69%24.51M-21.84%25.48M-12.27%138.39M-16.26%21M-10.52%38.82M380.67%45.98M-59.11%32.6M
Cost of revenue
Gross profit
Operating expense -38.70%143.48M-36.78%34.39M-38.12%30.67M-46.16%36.13M-32.86%42.3M-0.80%234.06M25.48%54.39M-20.96%49.55M3.33%67.1M-3.02%63.01M
Selling and administrative expenses -12.77%46.08M13.30%14.03M-21.68%10.4M-16.06%10.34M-23.81%11.32M-0.09%52.82M-1.02%12.38M-0.76%13.28M-6.87%12.32M7.91%14.85M
-General and administrative expense -12.77%46.08M13.30%14.03M-21.68%10.4M-16.06%10.34M-23.81%11.32M-0.09%52.82M-1.02%12.38M-0.76%13.28M-6.87%12.32M7.91%14.85M
Research and development costs -42.50%112.21M-44.09%24.48M-40.55%23.27M-49.58%29.58M-34.87%34.89M1.57%195.16M19.55%43.78M-23.38%39.13M11.39%58.67M3.49%53.57M
Other operating expenses -6.39%-14.81M-133.01%-4.12M-4.90%-3M2.37%-3.79M27.87%-3.91M-53.81%-13.92M69.43%-1.77M-62.02%-2.86M-307.02%-3.88M-873.74%-5.41M
Operating profit 20.29%-76.26M6.25%-31.31M-53.79%-16.51M45.02%-11.62M44.67%-16.83M-22.33%-95.67M-82.76%-33.39M44.41%-10.74M61.85%-21.13M-306.11%-30.41M
Net non-operating interest income expense -33.56%10.1M-52.61%1.52M-15.30%3.23M-38.11%2.57M-31.00%2.77M-8.41%15.2M-53.29%3.21M-4.09%3.82M27.55%4.15M62.13%4.02M
Non-operating interest income -33.50%10.1M-52.33%1.53M-15.30%3.23M-38.11%2.57M-31.00%2.77M-12.47%15.2M-53.33%3.21M-4.57%3.82M27.55%4.15M24.72%4.02M
Non-operating interest expense --9K------------------0--0--0--0--0
Other net income (expense) 181.10%382K309.94%701K15.42%-170K67.27%-127K60.38%-21K-101.40%-471K416.67%171K-5,125.00%-201K-360.40%-388K-100.16%-53K
Gain on sale of security 181.10%382K309.94%701K15.42%-170K67.27%-127K60.38%-21K-105.68%-471K416.67%171K-5,125.00%-201K-360.40%-388K83.84%-53K
Earnings from equity interest ----------------------0----------------
Special income (charges) --0------------------0--0--0--0--0
Income before tax 18.73%-65.78M3.09%-29.08M-88.88%-13.45M47.16%-9.18M46.78%-14.08M-190.23%-80.95M-162.20%-30.01M53.55%-7.12M66.59%-17.37M-152.01%-26.45M
Income tax 00.00%-4K0102.67%4K0-100.22%-4K-101.53%-4K-124.30%-217K-126.00%-150K257.28%368K
Net income 18.73%-65.78M3.09%-29.08M-94.81%-13.45M46.68%-9.18M47.51%-14.08M-172.30%-80.94M-156.30%-30.01M57.45%-6.9M67.24%-17.22M-152.84%-26.82M
Net income continuous Operations 18.73%-65.78M3.09%-29.08M-94.81%-13.45M46.68%-9.18M47.51%-14.08M-172.30%-80.94M-156.30%-30.01M57.45%-6.9M67.24%-17.22M-152.84%-26.82M
Minority interest income
Net income attributable to the parent company 18.73%-65.78M3.09%-29.08M-94.81%-13.45M46.68%-9.18M47.51%-14.08M-172.30%-80.94M-156.30%-30.01M57.45%-6.9M67.24%-17.22M-152.84%-26.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 18.73%-65.78M3.09%-29.08M-94.81%-13.45M46.68%-9.18M47.51%-14.08M-172.30%-80.94M-156.30%-30.01M57.45%-6.9M67.24%-17.22M-152.84%-26.82M
Basic earnings per share 20.00%-2.47.21%-1.03-88.46%-0.4946.88%-0.3448.00%-0.52-167.86%-3-246.88%-1.1157.38%-0.2667.68%-0.64-152.36%-1
Diluted earnings per share 20.00%-2.47.21%-1.03-88.46%-0.4946.88%-0.3448.00%-0.52-167.86%-3-246.88%-1.1157.38%-0.2667.68%-0.64-153.48%-1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.02%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.46%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+1.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+0.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.34%
Sample Name
Sample Code
 +11.49%
Sample Name
Sample Code
 +10.29%
4
Futu Holdings Ltd
FUTU
+10.23%
5
Hesai
HSAI
+9.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -